Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Drs. Fatemeh Ardeshir-Larijani and Mohamed Abazeed discuss a validated AI model that can predict how patients with advanced ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Cancer does not develop overnight. It can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that could pave the way for a new generation of immunotherapies. Cancer ...

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

Notably, when researchers artificially removed cholesterol from cancer cells using a cholesterol-depleting drug, even the most heat-resistant cells became vulnerable to hyperthermia treatment.

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...